Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Thyroxine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 16 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

Cisplatin 49 Capecitabine 42 Radiotherapy 33 Gemcitabine 33 apatinib 32 Oxaliplatin 32 Cyclophosphamide 32 Paclitaxel 30 Drug Therapy 30 Carboplatin 29 tislelizumab 27 Irinotecan 27 Docetaxel 26 Fluorouracil 25 Bevacizumab 23 Surgical Procedures, Operative 20 Nivolumab 19 pembrolizumab 18 fludarabine 18 Metformin 16 Exercise 16 Radiation 15 camrelizumab 14 S 1 (combination) 14 Control Groups 14 Blood Specimen Collection 14 Pemetrexed 13 anlotinib 11 Neoadjuvant Therapy 11 Laparoscopy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06971965 2025-05-14

MAeSTro-TSH

National Cancer Center, Korea

Phase NA Not yet recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡